5-HT2A/dopamine D3 antagonists (Roche)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Name5-HT2A/dopamine D3 antagonists (Roche)
Drug Alias NameRO-5463418RO-6805403
ClassificationSmall molecules
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D3 receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D3 receptor
Therapy Area/IndicationsCognition DisordersMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRoche Holding Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Holding Ag
Active IndicationsN/A
Inactive IndicationsCognition DisordersMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A